UNDER NEW OWNERSHIP AND MANAGEMENT since 2019, KRS Global Biotechnology is an FDA and DEA registered 503B Human Outsourcing Facility that provides sterile intravenous compounded products to hospitals, surgery centers, medical clinics, and medical institutions nationwide.
View Top Employees from KRS Global Biotechnology 503B State-of-the-Art FacilityWebsite | https://www.krsbio.com |
Revenue | $12 million |
Funding | $350000 |
Employees | 37 (34 on RocketReach) |
Address | 791 Park of Commerce Blvd Ste. 600, Boca Raton, Florida 33487, US |
Phone | (561) 886-9721 |
Fax | (866) 480-3322 |
Technologies |
JavaScript,
PHP,
Twitter
+23 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 446 Companies, NAICS Code 44 Companies, NAICS Code 4461 Companies |
Looking for a particular KRS Global Biotechnology 503B State-of-the-Art Facility employee's phone or email?
The KRS Global Biotechnology 503B State-of-the-Art Facility annual revenue was $12 million in 2024.
Ken Johnson is the Vice President of KRS Global Biotechnology 503B State-of-the-Art Facility.
34 people are employed at KRS Global Biotechnology 503B State-of-the-Art Facility.
KRS Global Biotechnology 503B State-of-the-Art Facility is based in Boca Raton, Florida.
The NAICS codes for KRS Global Biotechnology 503B State-of-the-Art Facility are [446, 44, 4461].
The SIC codes for KRS Global Biotechnology 503B State-of-the-Art Facility are [283, 28].